ConductScience.org, home

Trial · NCT00414466

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTED1 Placebo (0mg/Day)44
Overall StudySTARTED2 Gabapentin Low (1mg/Day)42
Overall StudySTARTED3 Gabapentin Medium (6mg/Day)41
Overall StudySTARTED4 Gabapentin High (30mg/Day)43
Overall StudyCOMPLETED1 Placebo (0mg/Day)42
Overall StudyCOMPLETED2 Gabapentin Low (1mg/Day)42
Overall StudyCOMPLETED3 Gabapentin Medium (6mg/Day)40
Overall StudyCOMPLETED4 Gabapentin High (30mg/Day)42
Overall StudyNOT COMPLETED1 Placebo (0mg/Day)2
Overall StudyNOT COMPLETED2 Gabapentin Low (1mg/Day)0
Overall StudyNOT COMPLETED3 Gabapentin Medium (6mg/Day)1
Overall StudyNOT COMPLETED4 Gabapentin High (30mg/Day)1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00414466/flow